Analysts at JP Morgan (JPM) are out with a report this morning upgrading shares of Dolby Laboratories, Inc. (DLB) with an ‘Overweight‘ from ‘Neutral‘ rating.
Dolby Laboratories Inc. Cl A shares are currently priced at 20.81x this year’s forecasted earnings, which makes them expensive compared to the industry’s 11.41x earnings multiple. Ticker has a forward P/E of 23.86 and t-12 price-to-sales ratio of 4.06. EPS for the same period is $1.96.
In the past 52 weeks, shares of San Francisco, California-based company have traded between a low of $37.25 and a high of $47.29 and are now at $40.77. Shares are down 10.20% year-over-year and 11.37% year-to-date.
Perrigo Company Public Limited Company (PRGO) was reiterated a ‘Buy’ by B. Riley & Co. analysts on Wednesday. The broker also raised its price target on the stock to $195 from $189.
PRGO shares recently gained $7.33 to $200.15. In the past 52 weeks, shares of Dublin, Ireland-based company have traded between a low of $125.37 and a high of $215.73. Shares are up 33.24% year-over-year and 15.44% year-to-date.
Vascular Solutions Inc. (VASC) was reiterated as ‘Buy’ with a $37 from $33 price target on Wednesday by Canaccord Genuity.
VASC shares recently gained $3.72 to $32.96. The stock is up more than 20% year-over-year and has gained roughly 8% year-to-date.
Vascular Solutions Inc. closed Tuesday at $29.24. The name has a total market cap of $566.94 million.
Echo Global Logistics, Inc. (ECHO) rating of ‘Buy’ was reiterated today at UBS with a price target increase of $36 from $31 (versus a $32.02 previous close).
On valuation measures, ECHO shares are currently priced at 46.92x this year’s forecasted earnings, compared to the industry’s 8.46x earnings multiple. Ticker has a forward P/E of 27.50 and t-12 price-to-sales ratio of 0.65. EPS for the same period is $0.71.
Over the past year, shares of Chicago, Illinois-based company have traded between a low of $17.47 and a high of $34.28 and are now at $33.31.
Shares of Broadcom Corp. (BRCM) are up $1.72 to $45.70 in mid-day trading after Canaccord Genuity reiterated its ‘Hold’ rating and increased its 12-month base case estimate on the name by 4 points to $51 a share. The firm believes however, investors may get a better entry point for company’s shares and that other large-cap names in the sector have higher potential for share appreciation over the next year.
BRCM shares recently gained $1.86 to $45.84. Canaccord’s target price suggests a potential upside of about 9% from the company’s current stock price.